NCT07463521 2026-03-17
MyVision
UCB Pharma
Phase 3 Not yet recruiting
Clinical Trials
8 trialsNCT07465289 2026-03-11
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
UCB Pharma
Phase 3 Not yet recruiting
NCT07304154 2026-03-10
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Gilead Sciences
Phase 1 Not yet recruiting
NCT07221838 2026-03-03
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4 Not yet recruiting
NCT07033559 2026-01-28
Detecting Fatigue From Voice in Generalised Myasthenia Gravis
Thymia Limited
Not yet recruiting
NCT07243366 2025-11-21
Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
Guangdong ProCapZoom Biosciences Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07226830 2025-11-12
BioDigit MG-03
BioSensics
Not yet recruiting
NCT07224386 2025-11-04
BioDigit MG-02
BioSensics
Not yet recruiting